Genome-wide Association Study of Development of Collateral Circulation for Patients With Coronary or Peripheral Artery Disease

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05043948

Acronym

GWAScollateral

Enrollment

400

Registered

2021-09-14

Start date

2015-08-21

Completion date

2025-12-31

Last updated

2021-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Collateral Circulation, Any Site, Coronary Disease, Peripheral Arterial Disease

Keywords

Genome-wide association, Collateral circulation

Brief summary

The purpose of this study is to evaluate the genome-wide association for the development of collateral circulation for patients with coronary or peripheral artery disease and to develop the molecular genetic treatment model based on genome-wide association data.

Interventions

DIAGNOSTIC_TESTBlood samples

for evaluation of the genome-wide association study

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age more than 20 * Chronic total occlusive lesion from the coronary or peripheral angiogram

Exclusion criteria

* Renal dysfunction * Hepatic dysfunction * Thrombocythemia or thrombocythemia * Planned major surgery in 1 year * History of gastrointestinal haemorrhage * Malignant tumor

Design outcomes

Primary

Measure	Time frame
Correlation between genome and collateral flow	5 years

Countries

South Korea

Contacts

Primary ContactJung-hee Ham, Project manager

cvcrc5@amc.seoul.kr82230104728

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026